| Role |
Name |
Disclosure |
Details |
| Author | Juan G Ochoa, MD, Assistant Professor of Neurology, Director, EEG Lab/Epilepsy Monitoring Unit, Department of Neurology, Shands Medical Center, University of Florida at Jacksonville | Pfizer Glaxo UCB Pharma | Details | | Coauthor | Willise Riche, MD, Epilepsy Program Coordinator, Department of Neurology, Shands Hospital; Educator, Department of Neurology, University of Phoenix at Jacksonville | Nothing to disclose | Details | | Medical Editor | Erasmo A Passaro, MD, Director, Comprehensive Epilepsy Program/Clinical Neurophysiology Lab, Bayfront Medical Center | Nothing to disclose | Details | | Pharmacy Editor | Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine | Nothing to disclose | Details | | Managing Editor | Jose E Cavazos, MD, PhD, Assistant Professor, Departments of Medicine (Neurology), Pharmacology, and Physiology, University of Texas Health Science Center at San Antonio | Glaxo-SmithKline Ortho-McNeil Neurologics UCB Pharma | Details | | CME Editor | Selim R Benbadis, MD, Professor, Director of Comprehensive Epilepsy Program, Departments of Neurology and Neurosurgery, University of South Florida School of Medicine, Tampa General Hospital | Nothing to disclose | Details | | Chief Editor | Nicholas Y Lorenzo, MD, Chief Editor, eMedicine Neurology; Consulting Staff, Neurology Specialists and Consultants | Nothing to disclose | Details |
|